Summary:
IRC Clinics is conducting a multicenter, randomized, double-blind, parallel-group, active controlled comparative study of the safety and efficacy of 2 dosing regimens of FV-100 versus valacyclovir administered for 7 days in subjects with uncomplicated AHZ(acute herpes zoster).
Qualified Participants Must:
• Be 50 years of age or older
•
Have not received the shingles vaccine
Qualified Participants May Receive:
$50 per visit, total compensation $600.